Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Refining the Association Between Body Mass Index and Atrial Fibrillation: G-Formula and Restricted Mean Survival Times.

Conner SC, Lodi S, Lunetta KL, Casas JP, Lubitz SA, Ellinor PT, Anderson CD, Huang Q, Coleman J, White WB, Benjamin EJ, Trinquart L.

J Am Heart Assoc. 2019 Aug 20;8(16):e013011. doi: 10.1161/JAHA.119.013011. Epub 2019 Aug 8.

2.

Multivariate meta-analysis model for the difference in restricted mean survival times.

Weir IR, Tian L, Trinquart L.

Biostatistics. 2019 Jun 8. pii: kxz018. doi: 10.1093/biostatistics/kxz018. [Epub ahead of print]

PMID:
31175828
3.

Survivorship Bias in Analyses of Immune Checkpoint Inhibitor Trials.

Conner SC, Trinquart L.

JAMA Oncol. 2019 Jun 6. doi: 10.1001/jamaoncol.2019.1187. [Epub ahead of print] No abstract available.

PMID:
31169896
4.

E-Values and quantitative epistemology.

Trinquart L, Galea S.

Am J Epidemiol. 2019 May 31. pii: kwz129. doi: 10.1093/aje/kwz129. [Epub ahead of print] No abstract available.

PMID:
31150042
5.

Adjusted restricted mean survival times in observational studies.

Conner SC, Sullivan LM, Benjamin EJ, LaValley MP, Galea S, Trinquart L.

Stat Med. 2019 Sep 10;38(20):3832-3860. doi: 10.1002/sim.8206. Epub 2019 May 22.

PMID:
31119770
6.

Restricted Mean Survival Times to Improve Communication of Evidence from Cancer Randomized Trials and Observational Studies.

Trinquart L, Bill-Axelson A, Rider JR.

Eur Urol. 2019 Aug;76(2):137-139. doi: 10.1016/j.eururo.2019.04.002. Epub 2019 Apr 26.

PMID:
31031048
7.

Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature.

Long MT, Ko D, Arnold LM, Trinquart L, Sherer JA, Keppel SS, Benjamin EJ, Helm RH.

Therap Adv Gastroenterol. 2019 Apr 2;12:1756284819832237. doi: 10.1177/1756284819832237. eCollection 2019. Review.

8.

Applying the E Value to Assess the Robustness of Epidemiologic Fields of Inquiry to Unmeasured Confounding.

Trinquart L, Erlinger AL, Petersen JM, Fox M, Galea S.

Am J Epidemiol. 2019 Jun 1;188(6):1174-1180. doi: 10.1093/aje/kwz063.

PMID:
30874728
9.

Proteomics Profiling and Risk of New-Onset Atrial Fibrillation: Framingham Heart Study.

Ko D, Benson MD, Ngo D, Yang Q, Larson MG, Wang TJ, Trinquart L, McManus DD, Lubitz SA, Ellinor PT, Vasan RS, Gerszten RE, Benjamin EJ, Lin H.

J Am Heart Assoc. 2019 Mar 19;8(6):e010976. doi: 10.1161/JAHA.118.010976.

10.

Design and Preliminary Findings From a New Electronic Cohort Embedded in the Framingham Heart Study.

McManus DD, Trinquart L, Benjamin EJ, Manders ES, Fusco K, Jung LS, Spartano NL, Kheterpal V, Nowak C, Sardana M, Murabito JM.

J Med Internet Res. 2019 Mar 1;21(3):e12143. doi: 10.2196/12143.

11.

Breast cancer and atrial fibrillation-A malignant combination?

Karnik AA, Benjamin EJ, Trinquart L.

Heart Rhythm. 2019 Mar;16(3):349-350. doi: 10.1016/j.hrthm.2018.11.016. Epub 2019 Jan 29. No abstract available.

PMID:
30709773
12.

Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes.

Pulit SL, Weng LC, McArdle PF, Trinquart L, Choi SH, Mitchell BD, Rosand J, de Bakker PIW, Benjamin EJ, Ellinor PT, Kittner SJ, Lubitz SA, Anderson CD.

Neurol Genet. 2018 Dec 3;4(6):e293. doi: 10.1212/NXG.0000000000000293. eCollection 2018 Dec.

13.

Living network meta-analysis was feasible when considering the pace of evidence generation.

Créquit P, Martin-Montoya T, Attiche N, Trinquart L, Vivot A, Ravaud P.

J Clin Epidemiol. 2019 Apr;108:10-16. doi: 10.1016/j.jclinepi.2018.12.008. Epub 2018 Dec 12.

PMID:
30552957
14.

Interpretation of time-to-event outcomes in randomized trials: an online randomized experiment.

Weir IR, Marshall GD, Schneider JI, Sherer JA, Lord EM, Gyawali B, Paasche-Orlow MK, Benjamin EJ, Trinquart L.

Ann Oncol. 2019 Jan 1;30(1):96-102. doi: 10.1093/annonc/mdy462.

15.

Registration of published randomized trials: a systematic review and meta-analysis.

Trinquart L, Dunn AG, Bourgeois FT.

BMC Med. 2018 Oct 16;16(1):173. doi: 10.1186/s12916-018-1168-6.

16.

Design analysis indicates Potential overestimation of treatment effects in randomized controlled trials supporting Food and Drug Administration cancer drug approvals.

Lord EM, Weir IR, Trinquart L.

J Clin Epidemiol. 2018 Nov;103:1-9. doi: 10.1016/j.jclinepi.2018.06.012. Epub 2018 Jul 2.

PMID:
30297036
17.

Effect of a Hospitalwide Quality Improvement Initiative to Promote High-Value Care.

Cordella N, Trinquart L, Hochberg S, Jacobson BC, Mishuris RG.

Jt Comm J Qual Patient Saf. 2018 Oct;44(10):623-625. doi: 10.1016/j.jcjq.2018.07.001. Epub 2018 Aug 22. No abstract available.

PMID:
30143446
18.

Design of non-inferiority randomized trials using the difference in restricted mean survival times.

Weir IR, Trinquart L.

Clin Trials. 2018 Oct;15(5):499-508. doi: 10.1177/1740774518792259. Epub 2018 Aug 3.

PMID:
30074407
19.

Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults.

Khurshid S, Choi SH, Weng LC, Wang EY, Trinquart L, Benjamin EJ, Ellinor PT, Lubitz SA.

Circ Arrhythm Electrophysiol. 2018 Jul;11(7):e006273. doi: 10.1161/CIRCEP.118.006273.

20.

Representation of obese participants in obesity-related cancer randomized trials.

Pestine E, Stokes A, Trinquart L.

Ann Oncol. 2018 Jul 1;29(7):1582-1587. doi: 10.1093/annonc/mdy138.

PMID:
29897392
21.

Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.

Staerk L, Wang B, Preis SR, Larson MG, Lubitz SA, Ellinor PT, McManus DD, Ko D, Weng LC, Lunetta KL, Frost L, Benjamin EJ, Trinquart L.

BMJ. 2018 Apr 26;361:k1453. doi: 10.1136/bmj.k1453.

22.

A mapping of 115,000 randomized trials revealed a mismatch between research effort and health needs in non-high-income regions.

Atal I, Trinquart L, Ravaud P, Porcher R.

J Clin Epidemiol. 2018 Jun;98:123-132. doi: 10.1016/j.jclinepi.2018.01.006. Epub 2018 Jan 31.

PMID:
29360559
23.

Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study.

Staerk L, Wang B, Lunetta KL, Helm RH, Ko D, Sherer JA, Ellinor PT, Lubitz SA, McManus DD, Vasan RS, Benjamin EJ, Trinquart L.

J Am Heart Assoc. 2017 Nov 14;6(11). pii: e006541. doi: 10.1161/JAHA.117.006541.

24.

Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.

Weng LC, Preis SR, Hulme OL, Larson MG, Choi SH, Wang B, Trinquart L, McManus DD, Staerk L, Lin H, Lunetta KL, Ellinor PT, Benjamin EJ, Lubitz SA.

Circulation. 2018 Mar 6;137(10):1027-1038. doi: 10.1161/CIRCULATIONAHA.117.031431. Epub 2017 Nov 12.

25.

Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis.

Créquit P, Chaimani A, Yavchitz A, Attiche N, Cadranel J, Trinquart L, Ravaud P.

BMC Med. 2017 Oct 30;15(1):193. doi: 10.1186/s12916-017-0954-x. Review.

26.

Evaluating alternative systems of peer review: a large-scale agent-based modelling approach to scientific publication.

Kovanis M, Trinquart L, Ravaud P, Porcher R.

Scientometrics. 2017;113(1):651-671. doi: 10.1007/s11192-017-2375-1. Epub 2017 Apr 3.

27.

The Changing Landscape of Atrial Fibrillation: Time to Target Heart Failure Prevention.

Ko D, Schnabel RB, Trinquart L, Benjamin EJ.

JACC Heart Fail. 2017 Aug;5(8):561-564. doi: 10.1016/j.jchf.2017.05.002. Epub 2017 Jun 14. No abstract available.

28.

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study.

Dechartres A, Trinquart L, Atal I, Moher D, Dickersin K, Boutron I, Perrodeau E, Altman DG, Ravaud P.

BMJ. 2017 Jun 8;357:j2490. doi: 10.1136/bmj.j2490. Erratum in: BMJ. 2017 Aug 8;358:j3806.

PMID:
28596181
29.

Reply to K.H. Eng et al.

Trinquart L, Jacot J, Conner SC, Porcher R.

J Clin Oncol. 2017 Feb;35(4):466-467. doi: 10.1200/JCO.2016.69.4539. Epub 2016 Oct 24. No abstract available.

PMID:
28129523
30.

Non-opioid analgesics in adults after major surgery: systematic review with network meta-analysis of randomized trials.

Martinez V, Beloeil H, Marret E, Fletcher D, Ravaud P, Trinquart L.

Br J Anaesth. 2017 Jan;118(1):22-31. doi: 10.1093/bja/aew391. Review.

31.

Research Techniques Made Simple: Workflow for Searching Databases to Reduce Evidence Selection Bias in Systematic Reviews.

Le Cleach L, Doney E, Katz KA, Williams HC, Trinquart L.

J Invest Dermatol. 2016 Dec;136(12):e125-e129. doi: 10.1016/j.jid.2016.09.019.

32.

The Global Burden of Journal Peer Review in the Biomedical Literature: Strong Imbalance in the Collective Enterprise.

Kovanis M, Porcher R, Ravaud P, Trinquart L.

PLoS One. 2016 Nov 10;11(11):e0166387. doi: 10.1371/journal.pone.0166387. eCollection 2016.

33.

Automatic classification of registered clinical trials towards the Global Burden of Diseases taxonomy of diseases and injuries.

Atal I, Zeitoun JD, Névéol A, Ravaud P, Porcher R, Trinquart L.

BMC Bioinformatics. 2016 Sep 22;17(1):392.

35.

Finding Alternatives to the Dogma of Power Based Sample Size Calculation: Is a Fixed Sample Size Prospective Meta-Experiment a Potential Alternative?

Tavernier E, Trinquart L, Giraudeau B.

PLoS One. 2016 Jun 30;11(6):e0158604. doi: 10.1371/journal.pone.0158604. eCollection 2016.

36.

Mental health surveillance after the terrorist attacks in Paris.

Gruebner O, Sykora M, Lowe SR, Shankardass K, Trinquart L, Jackson T, Subramanian SV, Galea S.

Lancet. 2016 May 28;387(10034):2195-6. doi: 10.1016/S0140-6736(16)30602-X. No abstract available.

PMID:
27302026
37.

Impact of interventions to improve the quality of peer review of biomedical journals: a systematic review and meta-analysis.

Bruce R, Chauvin A, Trinquart L, Ravaud P, Boutron I.

BMC Med. 2016 Jun 10;14(1):85. doi: 10.1186/s12916-016-0631-5. Review.

38.

Empirical evaluation of which trial characteristics are associated with treatment effect estimates.

Dechartres A, Trinquart L, Faber T, Ravaud P.

J Clin Epidemiol. 2016 Sep;77:24-37. doi: 10.1016/j.jclinepi.2016.04.005. Epub 2016 Apr 29. Review.

PMID:
27140444
39.

Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials.

Trinquart L, Attiche N, Bafeta A, Porcher R, Ravaud P.

Ann Intern Med. 2016 May 17;164(10):666-73. doi: 10.7326/M15-2521. Epub 2016 Apr 19.

PMID:
27089537
40.

Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates.

Ndounga Diakou LA, Trinquart L, Hróbjartsson A, Barnes C, Yavchitz A, Ravaud P, Boutron I.

Cochrane Database Syst Rev. 2016 Mar 10;3:MR000043. doi: 10.1002/14651858.MR000043.pub2. Review.

PMID:
26961577
41.

Why do we think we know what we know? A metaknowledge analysis of the salt controversy.

Trinquart L, Johns DM, Galea S.

Int J Epidemiol. 2016 Feb;45(1):251-60. doi: 10.1093/ije/dyv184. Epub 2016 Feb 17. Review.

PMID:
26888870
42.

Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials.

Trinquart L, Jacot J, Conner SC, Porcher R.

J Clin Oncol. 2016 May 20;34(15):1813-9. doi: 10.1200/JCO.2015.64.2488. Epub 2016 Feb 16. Review.

PMID:
26884584
43.
44.

Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer.

Créquit P, Trinquart L, Yavchitz A, Ravaud P.

BMC Med. 2016 Jan 20;14:8. doi: 10.1186/s12916-016-0555-0.

45.

Meta-Analysis of a Complex Network of Non-Pharmacological Interventions: The Example of Femoral Neck Fracture.

Mosseri J, Trinquart L, Nizard R, Ravaud P.

PLoS One. 2016 Jan 6;11(1):e0146336. doi: 10.1371/journal.pone.0146336. eCollection 2016.

46.

Differential Globalization of Industry- and Non-Industry-Sponsored Clinical Trials.

Atal I, Trinquart L, Porcher R, Ravaud P.

PLoS One. 2015 Dec 14;10(12):e0145122. doi: 10.1371/journal.pone.0145122. eCollection 2015.

47.

High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis.

Regnaux JP, Lefevre-Colau MM, Trinquart L, Nguyen C, Boutron I, Brosseau L, Ravaud P.

Cochrane Database Syst Rev. 2015 Oct 29;(10):CD010203. doi: 10.1002/14651858.CD010203.pub2. Review.

PMID:
26513223
48.

Sample size calculation for meta-epidemiological studies.

Giraudeau B, Higgins JP, Tavernier E, Trinquart L.

Stat Med. 2016 Jan 30;35(2):239-50. doi: 10.1002/sim.6627. Epub 2015 Aug 19.

PMID:
26286683
49.

Mapping epidemiology's past to inform its future: metaknowledge analysis of epidemiologic topics in leading journals, 1974-2013.

Trinquart L, Galea S.

Am J Epidemiol. 2015 Jul 15;182(2):93-104. doi: 10.1093/aje/kwv034. Epub 2015 May 14.

PMID:
25977517
50.

The Volume-Outcome Relationship in Critical Care: A Systematic Review and Meta-analysis.

Nguyen YL, Wallace DJ, Yordanov Y, Trinquart L, Blomkvist J, Angus DC, Kahn JM, Ravaud P, Guidet B.

Chest. 2015 Jul;148(1):79-92. doi: 10.1378/chest.14-2195. Review.

Supplemental Content

Loading ...
Support Center